PDIA3 and mucopolysaccharidosis: Additionally, a distinct set of genes, including ARL6IP6 and PDIA3, exhibited expression changes specific to neuronopathic MPS types/subtypes, suggesting their possible applications as biomarkers for neurodegeneration in MPS.